2[2]Bohannon NJ,Jack DB.Type Ⅱ diabetes:tips for managing your older patients[J].Geriatrics,1996,51:28-35
3[3]The Diabetes Control and Complication(DCCT) Reseach Group.Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabets Control and Complications Trial.Kidney Int,1995,47:1703-1720
4[4]Faller J,Hoss B.Medicamentous kidney protection in type 2 diabetic patients-is cheaper also more economical?A model calculation for Swiss health care[J].Schweiz Rundsch Med Prax,2002,91:836-844
5[5]Lewis EJ,Hunsicker LG,Clarke WR,et al.Renoprotective effect of the angiotensin -receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes[J].New Engl J Med,2001,345:851-860
6[6]Chobanian AV,Bakris GL,Black HR,et al.The seventh report of the joint national committee on prevention,detection,evaluation,and treatment of high blood pressure:the JNC 7 report[J].JAMA,2003,289:2560-2572
7[7]European society of Hypertension-European Society of Cardiology Guidelines Committee.2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension[J].J Hypertens,2003,21:1011-1053
8[8]American Diabetes Association.Treatment of hypertension in adults with diabetes[J].Diabetes Care,2002,25:199-201
4Kopple JD. Nutritional Management of Nondialyzed Patients with Chronic Renal Failure. In: Kopple JD, Massry SG, eds.Nutritional Management of Renal Disease, 2nd ed. Philadelphia: Lippincott Williams ＆ Wilkins, 2004. 379-414.
5Fouque D. Influence of Dietary Protein Intake on the Progression of Chronic Renal Insufficiency. In: Kopple JD, Massry SG, eds. Nutritional Management of Renal Disease, 2nd ed.Philadelphia: Lippincott Williams ＆ Wilkins, 2004. 241-259.
6Dikow R, Browatzki M, Adamczak M, et al. Nutritional Requirements of Diabetics with Nephropathy. In: Mitch WE,Klahr S, eds. Handbook of Nutrition and the Kidney. 4th ed.Philadelphia: Lippincott Williams ＆ Wilkins,2002. 157-177.
7Ibrabim HN, Nath KA, Hostetter TH. Nutritional Requirements of Diabetics with Nephropathy. In: Mitch WE, Klahr S,eds. Handbook of Nutrition and the Kidney. 3rd ed. Philadelphia: Lippincott-Raven, 1998. 166-200.
8Gonzalez EA, Martin KJ. Calcium, Phosphorus, and Vitamin D. In: Mitch WE, Klahr S, eds. Handbook of Nutrition and the Kidney. 3rd ed. Philadelphia: Lippincott-Raven. 1998:87-106.
9Walker JD, DoddsRA, Murrells TJ, et al. Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet, 1989, 2:1411-1415.
10Zeller K, Whittaker E. , Sullivan L, et al. Effect of restricting dietary protein on the progression of renal failure with insulindependent diabetes mellitus. N Engl J Med, 1991, 324:78-84.
4Kelly DJ, Aaitonen P, Cox A J, et al. Expression of the silt-diaphragn protein. Nephrin in experimental diabetic nephropathy: differing effects of anti-proteinuric herapies [J]. Nephrol Dial Transplant,2002,17(7): 1327-1332.
5Makino H, Mukoyama M, Sugawara A, et al. Roles of connective tissue growth factor and prostanoids in early streptozocin-induced diabetic rat kidney: the effect of aspirin treatment [J]. Clin Exp Nephrol,2003,7(1): 33-40.
6Navarro-Gonzulez JF,Mora-Fernandez C.The role of in flammatory cytokines in diabetic nephropathy [J].J Am Soc Nephrol, 2008,19 (3) : 433 -442.
7BuyukkocakS,Ozturk HS,Tamer MN,et al.Erythrocyte oxi- dant/antioxidant status of diabetic patients [J].J Endocfinol Invest, 2000,23 : 228-230.
8Ergul A,Johanse JS,Stromhaug C,et al.Vascular dysfunc- tion of venous bypass conduits is mediated by reactive oxygen species in diabetes:role of endothelin[J].Pharmacol Exp Ther,2005,313:70-77.
